论文部分内容阅读
Peripheral blood mesenchymal stem cells(PBMSCs)may be easily harvested from patient,therefore permitting autologous grafts for bone tissue engineering in future.However,the PBMSCs capabilities of survival,osteogenesis and producing new bone matrix in the bone defect area are still unclear.